Targeting the Epigenome in Hematopoietic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|4|242-252

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.4, 2006-05, pp. : 242-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Chemoprevention by Targeting the Epigenome

By  

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1925-1956

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

By  

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RSK2 in human malignancies

By Kang Sumin   Chen Jing  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1201-1210

Bentham Science Publishers

Access to resources Recommend Favorite